Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng Liang

Showing results (1141-1150 of 1,225) with videos related to

Pageof 123
Sort By:
Digestive Diseases and Sciences|November 14, 2019
Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis CPo-Yao Hsu, Cheng-Ting Hsu, Ming-Lun Yeh, et al.
Journal of Hepatology|February 17, 2020
Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infectionMing-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al.
Cancers|July 24, 2021
Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVRMing-Lun Yeh, Po-Cheng Liang, Pei-Chien Tsai, et al.
Ebiomedicine|May 24, 2017
Reduced Intellectual Ability in Offspring of Ovarian Hyperstimulation Syndrome: A Cohort StudyGu-Feng Xu, Cheng-Liang Zhou, Yi-Meng Xiong, et al.
Cell|January 16, 2010
Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysisDevon P Ryan, Magnus R Dias da Silva, Tuck Wah Soong, et al.
The Kaohsiung Journal of Medical Sciences|April 23, 2026
Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral TherapyChung-Feng Huang, Yi-Hung Lin, Pei-Chien Tsai, et al.
The Kaohsiung Journal of Medical Sciences|January 16, 2017
A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in TaiwanPei-Chien Tsai, Ta-Wei Liu, Meng-Hsuan Hsieh, et al.
Plos One|July 1, 2021
Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infectionHung-Yin Liu, Yi-Hung Lin, Pei-Ju Lin, et al.
Journal of the Chinese Medical Association : JCMA|June 2, 2021
The association between hepatitis C virus infection and renal functionGantsetseg Gantumur, Batbold Batsaikhan, Ching-I Huang, et al.
Biomedicines|November 11, 2022
Baseline Circulating miR-125b Levels Predict a High FIB-4 Index Score in Chronic Hepatitis B Patients after Nucleos(t)ide Analog TreatmentJyun-Yi Wu, Yi-Shan Tsai, Chia-Chen Li, et al.
Pageof 123

Showing results (1141-1150 of 1,225) with videos related to

Sort By:
Pageof 123
Digestive Diseases and Sciences|November 14, 2019
Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis CPo-Yao Hsu, Cheng-Ting Hsu, Ming-Lun Yeh, et al.
Journal of Hepatology|February 17, 2020
Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infectionMing-Lun Yeh, Chung-Feng Huang, Ching-I Huang, et al.
Cancers|July 24, 2021
Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVRMing-Lun Yeh, Po-Cheng Liang, Pei-Chien Tsai, et al.
Ebiomedicine|May 24, 2017
Reduced Intellectual Ability in Offspring of Ovarian Hyperstimulation Syndrome: A Cohort StudyGu-Feng Xu, Cheng-Liang Zhou, Yi-Meng Xiong, et al.
Cell|January 16, 2010
Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysisDevon P Ryan, Magnus R Dias da Silva, Tuck Wah Soong, et al.
The Kaohsiung Journal of Medical Sciences|April 23, 2026
Impact of Cardiometabolic Risk Factors and Steatotic Liver Disease on Liver-Related Outcomes in Patients With Chronic Hepatitis C After Curative Antiviral TherapyChung-Feng Huang, Yi-Hung Lin, Pei-Chien Tsai, et al.
The Kaohsiung Journal of Medical Sciences|January 16, 2017
A real-world impact of cost-effectiveness of pegylated interferon/ribavarin regimens on treatment-naïve chronic hepatitis C patients in TaiwanPei-Chien Tsai, Ta-Wei Liu, Meng-Hsuan Hsieh, et al.
Plos One|July 1, 2021
Anti-HCV antibody titer highly predicts HCV viremia in patients with hepatitis B virus dual-infectionHung-Yin Liu, Yi-Hung Lin, Pei-Ju Lin, et al.
Journal of the Chinese Medical Association : JCMA|June 2, 2021
The association between hepatitis C virus infection and renal functionGantsetseg Gantumur, Batbold Batsaikhan, Ching-I Huang, et al.
Biomedicines|November 11, 2022
Baseline Circulating miR-125b Levels Predict a High FIB-4 Index Score in Chronic Hepatitis B Patients after Nucleos(t)ide Analog TreatmentJyun-Yi Wu, Yi-Shan Tsai, Chia-Chen Li, et al.
Pageof 123